NR3C1 and cancer: For the tumor with the highest GR activity score (#17), the overlap with SERPINE1 expression was at 65.45%, whereas for the tumor with the lowest average GR activity score (#22), only 10% of the cancer cells had both high GR activity and a high expression of SERPINE1 (Figure 8B).